Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study. [electronic resource]
Producer: 20160519Description: 762-9 p. digitalISSN:- 1522-726X
- Aged
- Biomarkers -- blood
- Chi-Square Distribution
- China
- Coronary Angiography
- Coronary Artery Disease -- blood
- Coronary Thrombosis -- etiology
- Creatine Kinase, MB Form -- blood
- Drug-Eluting Stents
- Female
- Hemorrhage -- chemically induced
- Humans
- Intention to Treat Analysis
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Multivariate Analysis
- Myocardial Infarction -- diagnosis
- Odds Ratio
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Prospective Studies
- Prosthesis Design
- Risk Factors
- Time Factors
- Tirofiban
- Treatment Outcome
- Tyrosine -- administration & dosage
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.